Sebastián GH (@SebstnGH) header
Sebastián GH (@SebstnGH) profile picture

HPB Surgeon / SurgOnc. Tweets a título personal. No disclosures.

Right now in your mind!
Joined October 2010
Photo by Sebastián GH (@SebstnGH)Photo by Sebastián GH (@SebstnGH)Photo by Sebastián GH (@SebstnGH)Photo by Sebastián GH (@SebstnGH)Photo by Sebastián GH (@SebstnGH)Photo by Sebastián GH (@SebstnGH)Photo by Sebastián GH (@SebstnGH)Photo by Sebastián GH (@SebstnGH)Photo by Sebastián GH (@SebstnGH)Photo by Sebastián GH (@SebstnGH)
Sebastián GH retweeted
Un mundo perdido (cuando ya ni hace falta quemar los libros). Mi artículo de hoy @Milenio
5
110
8
259
6,929
Don't miss out! This webinar will bring together experts from Mexico, Brazil, the United States, and other countries across the Americas to examine current controversies and opportunities to improve multidisciplinary gallbladder cancer care. Register: ow.ly/66km50ZGHCF
7
1
14
2,076
París with Fuji
37
B&N series París 🇫🇷 FujiFilm X100VI
125
Saõ Paolo 🇧🇷 FujiFilm X100VI
1
161
Fujifilm X100VI
1
229
NICHE-2 absolutely delivers. Game over for chemo in dMMR colon cancer 💥🧬 In locally advanced dMMR colon cancer, FOxTROT already showed us chemo doesn’t work, and now NICHE-2 makes it undeniable. 💊 Neoadjuvant nivolumab + ipilimumab → • 99% pathologic response • 67% pathologic CR • Zero recurrences to date at 3 years 🪦 This is the final coffin nail for perioperative chemotherapy in this setting. ATOMIC is already on life support despite being published less than a year ago. The real question now: with Cercek’s rectal data, can we safely omit surgery next? At minimum, this should be the new standard. At maximum, it’s the start of a paradigm shift. @OncoAlert @TheGutOncLab #ESMO25
2
89
6
251
28,255
HIMALAYA is the 1st phase III trial to show 5-year OS in unresectable HCC! regular Durva/single Tremelimumab (Stride) 5-yr OS 19.6% vs 9.4% w/ Sorafenib ✅ Durable benefit ✅ No new late toxicities 🔹Benefit seen regardless of RECIST response #LiverCancer #HCC #Immunotherapy #STRIDE #OncoTwitter @OncoAlert @Larvol journal-of-hepatology.eu/art…
1
42
133
10,731
8
309
8
2,072
65,269
Sebastián GH retweeted
Esta columna de Manuel Vicent para despedir el año. Disfrutad esta noche con la familia y los amigos. El tiempo pasa volando.
40
3,538
162
11,356
945,291
Sesión de Cirugía Oncológica Carcinoma hepatocelular. @incanMX @SebstnGH @docenciaincan @ogarrieta @anelcabrera
4
6
479
Cirugía Robótica en la Institución líder del manejo en cáncer en México (Robotic Surgery in leading cancer hospital in México) @SurgOncInsight @SocSurgOnc @ESSOnews @SMEOMX @charlesbalchmd @incanMX @INCansm
This Post is from an account that no longer exists. Learn more
1
13
2
41
3,420
Sebastián GH retweeted
Le Temps de L'amour - Françoise Hardy youtu.be/riO_F5D1LBc?si=Pqtz…
21
1
53
3,529
Señor artista Andrew Bird 🎻
1
229
Si eres paciente en tratamiento oncológico o conoces a alguien con #cáncer: 👁️‼️❗️revisen las cédulas profesionales y certificaciones de sus médicos. 👉🏽 buholegal.com/general/ No hay quimioterapia que rescate una mala cirugía… Acudan con especialistas.
3
15
3
35
4,769
OCTOBER ISSUE: Analysis of the Extent of Liver Oncological Extended Resection for #IncidentalGallbladderCancer: How Much Is Too Much? #liverresection rdcu.be/dph9C @SocSurgOnc
1
34
3
90
13,016
Sebastián GH retweeted
No surprise, Mexico City was listed the #1 city in the world for the world's best cities for culture by TimeOut Magazine
33
453
111
2,148
325,524
Sebastián GH retweeted
🔥 Atezolizumab + bevacizumab vs surveillance in resected or ablated high-risk HCC (IMbrave050) @TheLancet doi.org/10.1016/S0140-6736(2… 👉First positive adjuvant study in HCC 🧐Practice changing? 👉Don’t miss our commentary in @TheLancet @myESMO @EASLnews @ILCAnews #livertwitter
1
45
3
111
16,242
Sebastián GH retweeted
🔥Neoadj. FOLFIRINOX vs gemcitabine-based RT for borderline resectable & resectable #PDAC #ESMO23 ✅ PREOPANC-2 phs III, 375 pts 👉62% completed FOLFIRINOX, 81% >4 cycles 👉 72% adj Gem 👉moS 21.9 vs 21.3 👉≥3 TEAEs 67% vs 60% 🧐 neoadj. CTx promising, but not yet there... @myESMO
1
58
3
116
22,604